cytrx-reached-an-agreement-with-the-us-fda-under-a-special-protocol-assessment-spa-for-a-global-pivotal-phase-iii-trial-with-aldoxorubicin-as-a-treatment-for-patients-with-soft-tissue-sarcomas

CytRx gets FDA nod Aldoxorubicin cancer trial

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based CytRx, a biopharmaceutical R&D company specializing in oncology, reached an agreement with the US FDA under a special protocol assessment (SPA)... Read more

kansas-bioscience-authority-kba-pays-received-usd400-000-to-pra-create-80-new-jobs

US state pays PRA $0.4 mn for creating jobs

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Authority (KBA) to create 80 new jobs this year... Read more

us-based-oncobiologics-and-china-based-zhejiang-huahai-pharma-are-looking-to-grab-a-chunk-of-the-global-usd40-billion-biosimilars-market

Huahai, Oncobiologics enter generics partnership

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: US-based Oncobiologics has signed an alliance agreement with China-based Zhejiang Huahai Pharmaceutical for the development, manufacture and commercialization... Read more

quintiles-begins-trading-on-nyse-under-q-symbol

Quintiles begins trading on NYSE under 'Q' symbol

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Quintiles has made the pricing of its initial public offering (IPO) of 23,684,210 shares of its common stock at a price to the public of $40.00 per share.... Read more

us-fda-asks-pregnant-women-suffering-from-migraine-not-to-take-valproate-sodium-as-it-may-cause-decreased-iq-in-children

FDA: Pregnant women must not take migraine drug

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US FDA is alerting healthcare providers and patients that medications including and related to valproate sodium can cause decreased intelligence quotient... Read more

ge-healthcare-s-new-fraction-collector-and-sample-pump-will-enhance-automation-of-kta-pure-protein-purification-system

GE launches new pump for protein purification

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GE Healthcare has launched a flexible fraction collector and robust and intelligent sample pump that is specifically designed to enhance ÄKTA pure, the... Read more

china-botanic-pharma-delisted-from-new-york-stock-exchange-for-noncompliance

NYSE delists China Botanic Pharma

  • China
  • |
  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: China Botanic Pharmaceutical received a notice from the NYSE due to its noncompliance with the plan that was previously submitted by the company on February... Read more

even-those-non-diabetic-individuals-who-have-high-blood-sugar-are-prone-to-alzheimer-s

High blood sugar causes Alzheimer’s in non-diabetics

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by the University of Arizona (UA), US, highlighted that elevated blood sugar levels are linked to risk for developing Alzheimer's disease.... Read more

bayer-healthcare-stops-phase-ii-trial-of-haemophilia-a-and-b-drug-bay-86-6150-after-detecting-neutralizing-antibody-led

Bayer stops haemophilia trial amidst drug safety concern...

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bayer HealthCare has stopped its phase II/III study testing its experimental treatment BAY 86-6150 on certain haemophilia A and B patients due to safety... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X